These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28158562)

  • 1. Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes.
    Russo A; Scardigli R; La Regina F; Murray ME; Romano N; Dickson DW; Wolozin B; Cattaneo A; Ceci M
    Hum Mol Genet; 2017 Apr; 26(8):1407-1418. PubMed ID: 28158562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
    Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
    Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease.
    Neelagandan N; Gonnella G; Dang S; Janiesch PC; Miller KK; Küchler K; Marques RF; Indenbirken D; Alawi M; Grundhoff A; Kurtz S; Duncan KE
    Nucleic Acids Res; 2019 Jan; 47(1):341-361. PubMed ID: 30357366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic TDP-43 is involved in cell fate during stress recovery.
    Lee YB; Scotter EL; Lee DY; Troakes C; Mitchell J; Rogelj B; Gallo JM; Shaw CE
    Hum Mol Genet; 2021 Dec; 31(2):166-175. PubMed ID: 34378050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
    Fallini C; Bassell GJ; Rossoll W
    Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR DNA-binding protein 43 inhibits inflammatory response and protects chondrocyte function by modulating RACK1 expression in osteoarthritis.
    Huang Y; Huang Q; Su H; Mai X; Feng E; Cao Z; Zeng X
    Biomed Pharmacother; 2017 Jan; 85():362-371. PubMed ID: 27890430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RACK1 mRNA translation is regulated via a rapamycin-sensitive pathway and coordinated with ribosomal protein synthesis.
    Loreni F; Iadevaia V; Tino E; Caldarola S; Amaldi F
    FEBS Lett; 2005 Oct; 579(25):5517-20. PubMed ID: 16212959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
    MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
    Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.
    Freibaum BD; Chitta RK; High AA; Taylor JP
    J Proteome Res; 2010 Feb; 9(2):1104-20. PubMed ID: 20020773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing repression is a major function of TDP-43 in motor neurons.
    Donde A; Sun M; Ling JP; Braunstein KE; Pang B; Wen X; Cheng X; Chen L; Wong PC
    Acta Neuropathol; 2019 Nov; 138(5):813-826. PubMed ID: 31332509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain.
    Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L
    Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.
    Fratta P; Sivakumar P; Humphrey J; Lo K; Ricketts T; Oliveira H; Brito-Armas JM; Kalmar B; Ule A; Yu Y; Birsa N; Bodo C; Collins T; Conicella AE; Mejia Maza A; Marrero-Gagliardi A; Stewart M; Mianne J; Corrochano S; Emmett W; Codner G; Groves M; Fukumura R; Gondo Y; Lythgoe M; Pauws E; Peskett E; Stanier P; Teboul L; Hallegger M; Calvo A; Chiò A; Isaacs AM; Fawzi NL; Wang E; Housman DE; Baralle F; Greensmith L; Buratti E; Plagnol V; Fisher EM; Acevedo-Arozena A
    EMBO J; 2018 Jun; 37(11):. PubMed ID: 29764981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.